SER
Serina Therapeutics, Inc. AMEX Listed Jan 21, 2000$1.84
Mkt Cap $18.4M
52w Low $1.22
9.3% of range
52w High $7.92
50d MA $1.94
200d MA $3.53
P/E (TTM)
-0.9x
EV/EBITDA
-0.7x
P/B
—
Debt/Equity
-5.3x
ROE
51843.2%
P/FCF
-1.1x
RSI (14)
—
ATR (14)
—
Beta
0.10
50d MA
$1.94
200d MA
$3.53
Avg Volume
4.6M
Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252, a POZ conjugate for the treatment of Parkinson's disease. The company also develops SER 227 for long-acting pain relief; SER 214 to treat Parkinson's disease; and SER 228 for the treatment of epilepsy. In addition, it develops POZ technology in lipid nanoparticle delivered ribonucleic acid vaccines for infectious diseases. Serina Therapeutics, Inc. was founded in 2006 and is based in Huntsville, Alabama.
601 Genome Way · Huntsville, AL 35806 · US
Data updated apr 27, 2026 12:46am
· Source: massive.com